Post Marketing Surveillance For General Drug Use To Assess The Safety And Efficacy Profile Of Viviant In Usual Practice.
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Bazedoxifene (Primary)
- Indications Metabolic bone diseases; Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors Pfizer
- 19 Jul 2017 Status changed from recruiting to completed.
- 22 May 2017 Planned End Date changed from 30 Apr 2017 to 31 May 2017.
- 22 May 2017 Planned primary completion date changed from 30 Apr 2017 to 31 May 2017.